Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Sep 20;22(9):1578. doi: 10.3390/molecules22091578

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effect of (PsT + NAC)^® on normal cells. (a) Viability of IEC-6 cells; (b) the viability of human gingival fibroblasts (b) was evaluated after treatment with NAC alone, PsT 86 mg/mL alone, (PsT 50 mg/mL + NAC)^®, and (PsT 10 mg/mL + NAC)^® and Staurosporine (STS) as a positive apoptosis control, for 24 h. The results showed that the combined treatments did not affect normal cells. Cell viability was assessed by MTT assay, performed for six independent experiments. One-way ANOVA was applied. * = significant differences compared to control cells (p < 0.05).

Effect of (PsT + NAC)^® on normal cells. (a) Viability of IEC-6 cells; (b) the viability of human gingival fibroblasts (b) was evaluated after treatment with NAC alone, PsT 86 mg/mL alone, (PsT 50 mg/mL + NAC)^®, and (PsT 10 mg/mL + NAC)^® and Staurosporine (STS) as a positive apoptosis control, for 24 h. The results showed that the combined treatments did not affect normal cells. Cell viability was assessed by MTT assay, performed for six independent experiments. One-way ANOVA was applied. * = significant differences compared to control cells (p < 0.05).